We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes.
- Authors
Samtani, Mahesh N; Raghavan, Nandini; Shi, Yingqi; Novak, Gerald; Farnum, Michael; Lobanov, Victor; Schultz, Tim; Yang, Eric; DiBernardo, Allitia; Narayan, Vaibhav A; Alzheimer's Disease Neuroimaging Initiative
- Abstract
The objective is to develop a semi-mechanistic disease progression model for mild cognitive impairment (MCI) subjects. The model aims to describe the longitudinal progression of ADAS-cog scores from the Alzheimer's disease neuroimaging initiative trial that had data from 198 MCI subjects with cerebrospinal fluid (CSF) information who were followed for 3 years.
- Publication
British journal of clinical pharmacology, 2013, Vol 75, Issue 1, p146
- ISSN
1365-2125
- Publication type
Journal Article
- DOI
10.1111/j.1365-2125.2012.04308.x